Drugs / AT-501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02436928 | Apr 2015 → Feb 2016 | — | Medigen Vaccine Biologics Corp. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AT-501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02436928 ↗ |